Vivos and Mayo Clinic are partnering for a first-in-human feasibility study for RadioGel®, which received FDA approval for its Investigational Device Exemption.
1 report, 1 independent
Updated Jul 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vivos and Mayo Clinic are partnering for a first-in-human feasibility study for RadioGel®, which received FDA approval for its Investigational Device Exemption.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vivos
California-based company, that provdes hardened underground shelters designed to withstand future disasters and life-extinction catastrophes
Nothing else this week.
-
Mayo Clinic
medical practice and medical research group based in Rochester, Minnesota, United States
- FDA